HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health, Beauty And Wellness News: GōL Bars, Soylent, IGC, Biotta, Neogen

This article was originally published in The Rose Sheet

Executive Summary

Rosa Foods adds CFO and VP of brand marketing to guide strategy for Soylent meal replacement brand; Neogen Listeria Right Now detection system has AOAC accreditation; Garden of Life's new bar launches in Warrior Dash; IGC markets cannabis supplement in California for Alzheimer's; Biotta Juice new flavors.

You may also be interested in...



Celsius Reaches Hong Kong, Soylent Tests LA: Health And Wellness News

Kayco into Beetology; REMFresh in US melatonin market; Danone sells Stonyfield; Campbell adds Pacific Foods as organic brand; and more news in brief.

Functional Beverage Brands Mark Soda Giants' Footprint In Healthy Future

Dr. Pepper Snapple and PepsiCo purchase functional beverage brands Bai Brands and KeVita, respectively, to position for growth in the booming healthy drink segment, which is outpacing soda sales growth.

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121791

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel